Comorbidity for psychiatric diseases as determinant in the diagnosis of covid-19 affected patients. Experiences in a hospital at the epicentre of the covid-19 epidemic in italy

Journal title PSICOBIETTIVO
Author/s Lorenzo M. Donini, Giuseppe Colosini, Livio A. Botrugno, Alessandra Romani, Anna Favalli, Andrea Lenzi, Aldo Rosano, Eleonora Poggiogalle
Publishing Year 2020 Issue 2020/2 Language Italian
Pages 11 P. 149-159 File size 156 KB
DOI 10.3280/PSOB2020-002012
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Italy has been deeply affected by the outbreak of the novel Sars-CoV-2 coronavirus infection, and the provinces of Brescia and Bergamo in Lombardy paid the highest price in terms of deaths from the disease. The aim of the present article is to retrospectively review the medical records of patients admitted to the Covid-19 medicine unit of an Italian hospital that was at the epicentre of the Covid-19 epidemic, identifying the factors that determined the clinical outcome of the hospitalization. Twenty-one out of 92 subjects (22.8%) admitted to the Covid-19 medicine unit died during the observation period. Compared to subjects who were discharged at home or in rehabilitation or residential facilities, patients who died had more frequently COPD (4.8 vs. 2.8%) and psychiatric diseases (19.5 vs. 7.1%). Duration of symptoms (i.e. fever, dyspnoea) before hospital admission was longer in patients who had an inauspicious outcome (6.3±5.9 vs. 3.5±3, p = 0.021). The logistic regression models (sex and age adjusted) showed a significant increase of risk of death in association with psychiatric disorders (OR = 5.9; CI 95%: 1.1-30.7). Further research should be prompted to investigate potential interactions between psychiatric medications and pathogenetic mechanisms in Covid-19.

Keywords: Covid-19; psychiatric diseases; psychiatric medications; mortality

Lorenzo M. Donini, Giuseppe Colosini, Livio A. Botrugno, Alessandra Romani, Anna Favalli, Andrea Lenzi, Aldo Rosano, Eleonora Poggiogalle, La comorbidità per patologie psichiatriche come determinante della prognosi in pazienti positivi all’infezione da Sars-CoV-2 Esperienza di un ospedale all’epicentro dell’epidemia in Italia in "PSICOBIETTIVO" 2/2020, pp 149-159, DOI: 10.3280/PSOB2020-002012